Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nagihan Bestepe is active.

Publication


Featured researches published by Nagihan Bestepe.


Cytopathology | 2017

Comparison of thyroid fine needle aspiration biopsy results before and after implementation of Bethesda classification

Didem Ozdemir; Nagihan Bestepe; S. Faki; Aydan Kilicarslan; Ömer Parlak; Reyhan Ersoy; Bekir Cakir

The Bethesda classification was introduced in 2008 to provide standardisation in the evaluation of thyroid fine needle aspiration cytology (FNAC). We compared the diagnostic value of pre‐Bethesda and Bethesda classification systems in the differentiation of benign and malignant thyroid nodules.


Endocrine | 2018

Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer

Abbas Ali Tam; Didem Ozdemir; Cevdet Aydin; Nagihan Bestepe; Serap Ulusoy; Nuran Sungu; Reyhan Ersoy; Bekir Cakir

PurposeWe aimed to investigate the relation between preoperative serum thyrotrophin (TSH) and clinicopathological features in patients with papillary thyroid carcinoma (PTC) and microcarcinoma (PTMC).MethodsPatients who underwent thyroidectomy and diagnosed to have benign nodular disease or PTC/PTMC in our clinic were evaluated retrospectively. Patients with a previous history of thyroid surgery, patients using antithyroid medications or thyroid hormone and patients with tumors known to be unresponsive to TSH were excluded.ResultsData of 1632 patients were analyzed. Histopathological diagnosis was benign in 969 (59.4%) and malignant in 663 (40.6%) patients. Preoperative median serum TSH was significantly higher in malignant compared to benign group (1.41 IU/dL vs. 0.98 IU/dL, p < 0.001). Malignancy risk increased gradually as going from hyperthyroidism to euthyroidism and hypothyroidism (20, 40.6, and 59.1%, respectively, p < 0.05). Serum TSH was lowest in benign nodular disease, higher in PTMC and highest in PTC (p < 0.001). This was also true when patients with positive antithyroid peroxidase/antithyroglobulin and with lymphocytic thyroiditis were excluded from the analysis (p < 0.001). Serum TSH was higher in patients with bilateral tumor, capsular invasion and lymph node metastasis (LNM) compared to patients with unilateral tumor, without capsule invasion and without LNM, respectively (p = 0.036, p = 0.002, and p = 0.001, respectively). Patients with aggressive variant PTC had higher serum TSH than nonaggressive ones (p < 0.05).ConclusionPreoperative serum TSH is associated with PTMC, PTC and LNM. Serum TSH seems to be related with thyroid cancer regardless of autoimmunity. With the present study, for the first time, we showed an association between serum TSH and aggressive variants of PTC.


Surgery | 2016

Malignancy risk and false-negative rate of fine needle aspiration cytology in thyroid nodules ≥4.0 cm

Nagihan Bestepe; Didem Ozdemir; Abbas Ali Tam; Fatma Dilek Dellal; Aydan Kilicarslan; Ömer Parlak; Reyhan Ersoy; Bekir Cakir


Endocrine Abstracts | 2018

Bilateral adrenalectomy for occult ectopic Cushing's syndrome in two patients with catastrophic hypercortisolism

Oya Topaloglu; Nagihan Bestepe; Bulent Yalcin; Mehmet Kilic; Melike Rusen Metin; Gulin Ucmak; Reyhan Ersoy; Bekir Cakir


Endocrine Abstracts | 2018

Presence of empty sella in a patient with clinical and biochemical diagnosis of acromegaly

Nagihan Bestepe; Cevdet Aydin; Abbas Ali Tam; Karabekir Ercan; Reyhan Ersoy; Bekir Cakir


20th European Congress of Endocrinology | 2018

Detection of pulmonary metastases with 18F-Fluorocholine PET/CT and treatment of refractory hypercalcemia with denosumab in a patient with long term parathyroid carcinoma

Nagihan Bestepe; Oya Topaloglu; Cigdem Soydal; Nilüfer Yıldırım; Reyhan Ersoy; Bekir Cakir


20th European Congress of Endocrinology | 2018

Teriparatide treatment in a patient with atypical femoral fractures associated with long-term bisphosphonate therapy

Nagihan Bestepe; Cevdet Aydin; Berna Evranos; Oya Topaloglu; Reyhan Ersoy; Bekir Cakir


Endocrine Abstracts | 2017

The rare cause of primary hyperparathyroidism: Parathyroid Carcinoma

Nagihan Bestepe; Didem Ozdemir; Sefika Burcak Polat; Berna Evranos; Reyhan Ersoy; Bekir Cakir


19th European Congress of Endocrinology | 2017

Evaluation of differentiated thyroid cancer patients according to different scoring systems: a single center experience

Bekir Cakir; Cevdet Aydin; Berna Ogmen; Ali Abbas Tam; Sefika Burcak Polat; Husniye Baser; Neslihan Cuhaci; Fatma Dilek Kahramanca; Nagihan Bestepe; Cuneyt Bilginer; Sevgul Faki; Mehmet Kilic; Aydan Kilicarslan; Reyhan Ersoy


19th European Congress of Endocrinology | 2017

Predictive value of CHAID Algorithm in the diagnosis of malignancy in thyroid nodules with Bethesda III (AUS/FLUS) cytology

Reyhan Ersoy; Cevdet Aydin; Oya Topaloglu; Didem Ozdemir; Husniye Baser; Fatma Neslihan Cuhaci; Tam Abbas Ali; Berna Ogmen; Sefika Burcak Polat; Fatma Dilek Dellal; Ahmet Dirikoc; Nagihan Bestepe; Mehmet Kilic; Ayşegül Aksoy Altınboğa; Bekir Cakir

Collaboration


Dive into the Nagihan Bestepe's collaboration.

Top Co-Authors

Avatar

Bekir Cakir

Yıldırım Beyazıt University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cevdet Aydin

Yıldırım Beyazıt University

View shared research outputs
Top Co-Authors

Avatar

Oya Topaloglu

Yıldırım Beyazıt University

View shared research outputs
Top Co-Authors

Avatar

Sefika Burcak Polat

Yıldırım Beyazıt University

View shared research outputs
Top Co-Authors

Avatar

Aydan Kilicarslan

Yıldırım Beyazıt University

View shared research outputs
Top Co-Authors

Avatar

Fatma Dilek Dellal

Yıldırım Beyazıt University

View shared research outputs
Top Co-Authors

Avatar

Abbas Ali Tam

Yıldırım Beyazıt University

View shared research outputs
Top Co-Authors

Avatar

Berna Evranos

Yıldırım Beyazıt University

View shared research outputs
Researchain Logo
Decentralizing Knowledge